Our findings suggest that a direct MYCN-mediated repression/alteration of p53 genotoxic responses may contribute to treatment failure in MYCN-amplified neuroblastoma by further raising the threshold for apoptosis and promoting mutagenic proliferation in the presence of DNA damage. This evidence concerns the gene TP53 and neuroblastoma.